Allergen Immunotherapy: Optimal Duration for Respiratory Allergy

Current Treatment Options in Allergy · Published 2024-11-14 · DOI 10.1007/s40521-024-00377-6

Authors being retrieved — see the publisher record. https://doi.org/10.1007/s40521-024-00377-6

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2024

Related articles

• High degree of remission in pediatric severe asthma patients treated with biologics in a real-world setting · World Allergy Organization Journal · 2026 · Cites or is cited by this article
• Update on the Role of the Microbiome in Chronic Rhinosinusitis · Current Treatment Options in Allergy · 2024 · Same journal
• Skin Infections in Atopic Dermatitis: Treatment Challenges · Current Treatment Options in Allergy · 2025 · Same journal
• Paraclinics in Chronic Spontaneous Urticaria: Are They Useful as Biomarkers? · Current Treatment Options in Allergy · 2026 · Same journal
• Psychological Stress and Urticaria: Pathophysiologic and Therapeutic Updates · Current Treatment Options in Allergy · 2024 · Same journal
• Are Allergen Avoidance Measures Prerequisite for House Dust Mite Allergen Immunotherapy? · Current Treatment Options in Allergy · 2026 · Same journal
• Risk of Anaphylaxis Associated with Cold Urticaria · Current Treatment Options in Allergy · 2024 · Same journal
• Urticaria in Children: Common Points and Differences with Treatment in Adults · Current Treatment Options in Allergy · 2025 · Same journal
• How to Build a Severe Asthma Clinic in Low- and Middle-Income Countries? · Current Treatment Options in Allergy · 2025 · Same journal
• Multidisciplinary Management of Pediatric Chronic Rhinosinusitis with Nasal Polyposis · Current Treatment Options in Allergy · 2024 · Same journal